ClinConnect ClinConnect Logo
Search / Trial NCT06936319

Counterpressure Maneuvers in Postural Orthostatic Tachycardia Syndrome

Launched by MEDICAL UNIVERSITY INNSBRUCK · Apr 10, 2025

Trial Information

Current as of May 10, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help people with Postural Orthostatic Tachycardia Syndrome (POTS), a condition that makes it hard for some individuals to stand up without feeling dizzy or experiencing a rapid heartbeat. Over a period of 14 days, participants will learn and practice specific exercises called counterpressure maneuvers (CPM) that aim to improve their symptoms. The trial will compare the effects of these maneuvers with standard care practices to see if they can help reduce symptoms, fatigue, and improve the overall quality of life for those affected by POTS.

To participate, individuals need to be diagnosed with POTS and be between 18 and 80 years old. They should be stable on their medications and able to stand for at least two minutes. Throughout the study, participants will receive guidance on how to perform these maneuvers safely, and they will be monitored closely. Those in the treatment group will attend additional training sessions to learn the CPM techniques while their heart rate and blood pressure are monitored. Participants can expect several visits over the course of the study, including both in-person and phone check-ins. This study aims to find ways to better manage POTS symptoms and improve daily living for those affected.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • POTS diagnosis
  • 18 to 80 years of age at time of consent
  • stable medication in the seven days prior to the baseline visit
  • able to provide written informed consent
  • Exclusion Criteria:
  • participation in other interventional trials
  • pregnant or breastfeeding females
  • on treatment with vasoactive medications including medications for heart rate control
  • acute infections at the time of enrolment or in the two weeks before
  • acute pain
  • surgery in the last three months
  • inability or contraindication for performing hip and knee flexion, hip adduction or squatting
  • inability to stand for at least two minutes
  • Any other cardiological, internal, psychiatric or neurological condition, which may prevent engagement in the sturdy procedures in the judgement of the investigator

About Medical University Innsbruck

The Medical University of Innsbruck is a leading academic institution dedicated to advancing healthcare through innovative research and clinical excellence. Situated in the heart of the Austrian Alps, it combines a rich tradition of medical education with cutting-edge scientific inquiry. As a prominent sponsor of clinical trials, the university focuses on a broad spectrum of medical fields, emphasizing the translation of research findings into practical applications for patient care. With a commitment to ethical standards and rigorous methodologies, the Medical University of Innsbruck strives to enhance treatment options and improve health outcomes globally through its collaborative efforts in clinical research.

Locations

Innsbruck, Tirol, Austria

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported